RXRX Recursion Pharmaceuticals Inc

$5.53

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/6/2025

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that decodes biology by integrating technological innovations in biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company is headquartered in Salt Lake City, Utah.

Website: https://www.recursion.com

Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1601830
Address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, US
Valuation
Market Cap
$2.21B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
2.14
Performance
EPS
$-1.69
Dividend Yield
—
Profit Margin
0.00%
ROE
-61.90%
Technicals
50D MA
$6.73
200D MA
$6.92
52W High
$12.36
52W Low
$3.79
Fundamentals
Shares Outstanding
395M
Target Price
$8.71
Beta
0.99

RXRX EPS Estimates vs Actual

● Estimated
● Actual

RXRX News & Sentiment

Oct 03, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Recursion Pharmaceuticals ( RXRX ) Surges 8.2%: Is This an Indication of Further Gains?
Recursion Pharmaceuticals (RXRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Sep 29, 2025 • Motley Fool SOMEWHAT-BULLISH
Nvidia Has Invested in These 6 Companies. Should You Follow Suit?
The world's most valuable company holds stakes in a number of smaller tech players.
Sep 28, 2025 • Motley Fool SOMEWHAT-BULLISH
Where Will Recursion Pharmaceuticals Be in 5 Years?
Could investing in this stock be an underrated way to profit from the rapidly expanding AI industry?
Sep 28, 2025 • Motley Fool SOMEWHAT-BULLISH
The Biotech Stock That's Too Risky for Most Investors
It's unclear how long it's going to be before this company has a product to sell.
Sep 27, 2025 • Motley Fool SOMEWHAT-BULLISH
10 Hidden-Gem AI Stocks to Buy Right Now
From AI-powered insurance bots to drug discovery platforms, these overlooked stocks offer pure-play exposure to artificial intelligence without trillion-dollar valuations.
Sep 26, 2025 • Benzinga NEUTRAL
Jim Cramer Says This Financial Stock Is A 'Total Spec,' Likes Dutch Bros, - Dutch Bros ( NYSE:BROS ) , American Bitcoin ( NASDAQ:ABTC )
On CNBC's "Mad Money Lightning Round," Jim Cramer said he likes Dutch Bros ( NYSE: BROS ) . He recommended buying some now and then buying some of the stock in the $40s. On Sept. 24, RBC Capital analyst Logan Reich reiterated Dutch Bros with an Outperform and maintained a price target of $85.
Sentiment Snapshot

Average Sentiment Score:

0.198
50 articles with scored sentiment

Overall Sentiment:

Bullish

RXRX Reported Earnings

Feb 25, 2025
Dec 31, 2024 (Pre market)
-0.11 Surprise
  • Reported EPS: $-0.53
  • Estimate: $-0.42
  • Whisper: —
  • Surprise %: -27.2%
Nov 06, 2024
Sep 30, 2024 (Post market)
0.01 Surprise
  • Reported EPS: $-0.34
  • Estimate: $-0.35
  • Whisper: —
  • Surprise %: 2.9%
Aug 08, 2024
Jun 30, 2024 (Pre market)
0.0 Surprise
  • Reported EPS: $-0.40
  • Estimate: $-0.40
  • Whisper: —
  • Surprise %: 0.0%
May 09, 2024
Mar 31, 2024 (Post market)
0.03 Surprise
  • Reported EPS: $-0.39
  • Estimate: $-0.42
  • Whisper: —
  • Surprise %: 7.1%
Feb 27, 2024
Dec 31, 2023 (Post market)
0.03 Surprise
  • Reported EPS: $-0.42
  • Estimate: $-0.45
  • Whisper: —
  • Surprise %: 6.7%
Nov 09, 2023
Sep 30, 2023 (Pre market)
-0.05 Surprise
  • Reported EPS: $-0.43
  • Estimate: $-0.38
  • Whisper: —
  • Surprise %: -13.2%
Aug 08, 2023
Jun 30, 2023 (Pre market)
-0.01 Surprise
  • Reported EPS: $-0.38
  • Estimate: $-0.37
  • Whisper: —
  • Surprise %: -2.7%
May 08, 2023
Mar 31, 2023 (Pre market)
0.01 Surprise
  • Reported EPS: $-0.34
  • Estimate: $-0.35
  • Whisper: —
  • Surprise %: 2.9%
Feb 27, 2023
Dec 31, 2022 (Post market)
-0.02 Surprise
  • Reported EPS: $-0.31
  • Estimate: $-0.29
  • Whisper: —
  • Surprise %: -6.9%

Financials